Apoptotic cell death: Its implications for imaging in the next millennium

European Journal of Nuclear Medicine

Volumn 27, Issue 3, 2000, Pages 359-367

  Blankenberg, Francis G ^a   Tait, Jonathan F ^b   Strauss, H William ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Apoptosis; Imaging methods; Programmed cell death

Indexed keywords

LIPOCORTIN 5;

ANIMAL EXPERIMENT; APOPTOSIS; ARTHROPATHY; BONE MARROW DISEASE; CELL DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CYTOLOGY; HEART DISEASE; HUMAN; IMAGING; IMAGING SYSTEM; LUNG DISEASE; MEDICAL DECISION MAKING; NONHUMAN; ONCOLOGY; ORGAN TRANSPLANTATION; PATHOPHYSIOLOGY; RAT; REVIEW; TISSUE SPECIFICITY;

EID: 0034033507     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050046     Document Type: Review

References (55)

1. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
2. The London Economist. Science and technology; honorable death. 4 May 1996, pp 83-84.
3. Rimon G, Bazenet CE, Philpott KL, et al. Increased surface phosphatidylserine is an early marker of neuronal apoptosis. J Neurosci Res 1997; 48: 563-570.
4. Krams SM, Martinez OM. Apoptosis as a mechanism of tissue injury in liver allograft rejection. Semin Liver Dis 1998; 18: 153-167.
5. Olivetti G, Abbi R, Quani F, et al. Apoptosis in the failing human heart. N Engl J Med 1997; 336: 1131-1141.
6. Darzykiewicz Z. Apoptosis in antitumor strategies: Modulation of cell cycle or differentiation. J Cell Biol 1995; 58: 151-159.
7. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
8. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998; 281: 1305-1308.
9. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.
10. Thornberry NA, Lazebnik Y. Caspases: Enemies within. Science 1998; 281: 1312-1316.
11. Evan G, Littlewood T. A matter of life and cell death. Science 1998; 281: 1317-1321.
12. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281: 1322-1325.
13. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic lymphocytes. J Exp Med 1995; 182: 1597-1601.
14. Zwaal RFA, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 1121-1132.
15. van Engeland M, Nieland LJW, Ramaekers FCS, et al. Annex-in V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998; 31: 1-9.
16. Allen RT, Hunter III WJ, Agrawal DK. Morphological and biochemical characterization and analysis of apoptosis. JPM 1997; 37: 215-228.
17. van Heerde WL, de Groot PG, Reutelingsperger CPM. The complexity of the phospholipid binding protein annexin V. Thromh Haemost 1995; 73: 172-179.
18. Tait JF. Clinical application of annexins. In: Seton BA, ed. Annexins: molecular structure to cellular function. R.G. Landes; 1996: 213-220.
19. O'Brien IEW, Rentingsperger CPM, Holdaway KM. Annexin-V and TUNEL use in monitoring the progression of apoptosis in plants. Cytometry 1997; 29: 28-33.
20. Abrams MJ, Juweid M, tenKate CI, et al. Technetium-99-m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med 1990; 31: 2022-2028.
21. Stratton JR, Dewhurst TA, Kasina S, et al. Selective uptake of radiolabeled annexin V on acute porcine left atrial thrombi. Circulation 1995; 92: 3113-3121.
22. Blankenberg FG, Katsikis PD, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 1998; 95: 6349-6354.
23. 99mTc annexin V. J Nucl Med 1999; 40: 184-191.
24. Blankenberg FG, Storrs RW, Naumovski L, et al. Detection of apoptotic cell death by proton nuclear magnetic resonance spectroscopy. Blood 1996; 87: 1951-1956.
25. Blankenberg FG, Katsikis PD, Storrs RW, et al. Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. Blood 1997; 89: 3778-3786.
26. 1H nuclear magnetic resonance spectroscopy. Neurosci Lett 1996; 212: 151-154.
27. 1H MRS in acute traumatic brain injury. J Magn Reson Imaging 1998; 8: 829-840.
28. 1H nuclear magnetic resonance correspond to lipid droplets. Cancer Res 1997; 57: 407-414.
29. 1H- NMR-detectable mobile lipid in stimulated lymphocytes: relationship to cellular activation, the cell cycle, and phosphatidylcholine-specific phospholipase C. Biochem Biophys Res 1997; 239: 868-874.
30. 1H NMR diffusion spectroscopy of BT4 C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response. Cancer Res 1998; 58: 3791-3799.
31. D'Arceuil HE, de Crespigny AJ, Rother J, et al. Diffusion and perfusion magnetic resonance imaging of the evolution of hypoxic ischemic encephalopathy in the neonatal rabbit. J Magn Reson Imaging 1998; 8: 820-888.
32. Du C, Hu R, Csernansky CA, et al. Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J Cereb Blood Flow Metab 1996; 16: 195-201.
33. 99mTc radiolabeled annexinV. Stroke 1998; 29: 330.
34. Rutherford MA, Pennock JM, Counsell SJ, et al. Abnormal magnetic resonance signal in the internal capsule predicts poor neurodevelopmental outcome in infants with hypoxic-ischemic encephalopathy. Pediatrics 1998; 102: 323-328.
35. Oka A, Belliveau MJ, Rosenberg PA, et al. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J Neurosci 1993; 13: 1441-1453.
36. Pulera MR, Adams LM, Liu H, et al. Apoptosis in a neonatal rat model of cerebral hypoxia-ischemia. Stroke 1998; 29: 2622-2630.
37. D'Arceuil HE, Blankenberg FG, Tait JF, et al. Radionuclide scanning combined with MR diffusion imaging investigation of apoptosis in neonatal rabbit HIE [abstract]. Pediatr Res 1998; 43: 317A.
38. Cotman CW, Anderson AJ. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol Neurobiol 1995; 10: 19-45.
39. Lau DM, Siegel MJ, Hildebolt CF, et al. Bronchiolitis obliterans syndrome: thin-section CT diagnosis of obstructive changes in infants and young children after lung transplantation. Radiology 1998; 208: 783-788.
40. McAdams HP, Rosado-de-Christenson ML, Wehunt WD, et al. The alphabet soup revisted: the chronic interstitial pneumonias in the 1990s. Radiographics 1996; 16: 1009-1033.
41. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996; 335: 1182-1195.
42. Greve G, Rotevatn S, Svendby K, et al. Early morphologic changes in cat heart muscle cells after acute coronary artery occlusion. Am J Pathol 1990; 136: 273-283.
43. Yaoita H, Ogawa K, Maehara K, et al. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor [see comments]. Circulation 1998; 97: 276-281.
44. Hara H, Friedlander RM, Gagliardini V, et al. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 1997; 94: 2007-2012.
45. Geng Y-J, Holm J, Hygren S, et al. Expression of the macrophage scavenger receptor in atheroma. Arterioscler Thromb Vasc Biol 1995; 15: 1995-2002.
46. Torzewski J, Oldroyd R, Lachmann P, et al. Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible intiating event in atherosclerotic lesion formation. Arterioscler Thromb Vasc Biol 1996; 16: 673-677.
47. Grandaliano G, Gesualdo L, Ranieri E, et al. Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection. Transplantation 1997; 63: 414-420.
48. Vriens PW, Blankenberg FG, Stoot JH, et al. The use of Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. J Thorac Cardiovasc Surg 1998; 116: 844-853.
49. Niemeyer CM, Gelber RD, Tarbell NJ, et al. Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (protocol 81-01 update). Blood 1991; 78: 2514-2519.
50. Uhl M, Allmann KH, Ihling C, et al. Cartilage destruction in small joints by rheumatoid arthritis: assessment of fat-suppressed three-dimensional gradient-echo MR pulse sequences in vitro. Skeletal Radiol 1998; 27: 677-682.
51. Nakashima Y, Sun DH, Traindade MC, et al. Induction of macrophage C-C chemokine expression by titanium alloy and bone cement particles. J Bone Joint Surg [Br] 1999; 81: 155-162.
52. Blankenberg FG, Strauss HW. Non-invasive diagnosis of acute heart- or lung-transplant rejection using radiolabeled annexin V. Pediatr Radiol 1999; 29: 299-305.
53. Lamb JR, Friend SH. Which questimate is the best questimate? Predicting chemotherapeutic outcomes. Nature Med 1997; 9: 962-963.
54. Martin DS, Schwartz GK. Chemotherapeutically induced DNA damage, ATP depletion, and the apoptotic biochemical cascade. Oncol Res 1997; 9: 1-5.
55. Zhang J, Dawson VL, Dawson TM, et al. Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity. Science 1994; 263: 687-689.